By integrating AFP, a well‐established tumor marker with confirmed relevance in AFPGC[2, 19] that reflects immune system dynamics,[50] with NLR, an indicator of systemic inflammation,[51] ANLiM offers a comprehensive view of the tumor's biological aggressiveness and the host's immune response. The gene discussed is AFP; the disease is neoplasm.